Prediction of the pharmacokinetics of pemetrexed with a low test dose: A proof-of-concept study.

Boosman, René J; de Rouw, Nikki; Huitema, Alwin D R; Burgers, Jacobus A; Ter Heine, Rob

Boosman, René J; de Rouw, Nikki; Huitema, Alwin D R; Burgers, Jacobus A; Ter Heine, Rob.

Afiliación

Boosman RJ; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Amsterdam, the Netherlands.
de Rouw N; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
Huitema ADR; Department of Pharmacy, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
Burgers JA; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Ter Heine R; Department of Clinical Pharmacy, Utrecht University Medical Center, Utrecht University, Utrecht, the Netherlands.

Br J Clin Pharmacol ; 89(2): 699-704, 2023 02.

Article en En | MEDLINE | ID: mdl-36053283

Asunto(s)

Antineoplásicos; Neoplasias Pulmonares; Humanos; Pemetrexed/efectos adversos; Pemetrexed/farmacocinética; Antineoplásicos/farmacocinética; Neoplasias Pulmonares/tratamiento farmacológico

Palabras clave

NONMEM; low test dose; microdose; pemetrexed; pharmacokinetics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google